Vaginal / Vulvar Cancer

Two rare but related gynecologic cancers of the lower genital tract, with the same major pathways: HPV-driven in younger women and chronic skin disease in older women. Standard oncology care is the primary treatment; holistic nutrition and lifestyle work alongside to support recovery and ease treatment side effects.

Hormonal & Women's Health Evidence-Based

Last updated:

โš ๏ธ Treatment safety: please read first. The nutrition and supplement approaches on this page are meant to work alongside cancer treatment, never to replace or delay it. Never stop, delay or change your treatment without your oncology team's guidance. Doing so can be dangerous. Several supplements interact with chemotherapy and other cancer treatments, so talk to your oncology team or pharmacist before starting anything on this page.

What Is Vaginal / Vulvar Cancer?

Vaginal and vulvar cancers are malignancies of the lower female genital tract. Vaginal cancer arises in the vaginal canal; vulvar cancer arises in the external genitalia (labia majora, labia minora, clitoris, perineum).

Both are rare: vulvar cancer accounts for several thousand new US cases a year, and vaginal cancer makes up only 1 to 2% of cancers of the female genital tract.10 Squamous cell carcinoma is the most common type in both. The other histologic subtypes are adenocarcinoma, melanoma and sarcoma. Importantly, two distinct biological pathways produce these cancers: an HPV-related pathway in younger women (high-risk HPV types 16 and 18 driving precancer to cancer), and a non-HPV pathway in older women, usually arising from chronic vulvar skin diseases such as lichen sclerosus2.

Staging follows the FIGO system (I to IV). Because vulvar cancer is visible on self-exam, and vulvar and vaginal cancers can both be found on a pelvic exam, earlier detection is possible with regular checks.

The uterus, cervix, vagina and vulva drawn from the front, with a tumor on the wall of the vagina

Squamous Cell Carcinoma (the most common)

The dominant histology in both vulvar and vaginal cancer. Two major pathways: HPV-related (younger women, arises from VIN/VaIN precancer) and non-HPV (older women, arises from lichen sclerosus or chronic vulvar dermatosis). HPV-related disease tends to have a slightly better prognosis stage for stage.

  • โ†’Hallmarks: Visible or palpable lesion, persistent itching, bleeding, ulcer or pigmented patch
  • โ†’Standard care: Wide local excision/​vulvectomy + sentinel-node biopsy4 + risk-adjusted radiation5/chemo

Adenocarcinoma (uncommon)

Arises from glandular tissue (Bartholin's glands in the vulva, vaginal adenosis in the vagina).

  • โ†’Hallmarks: Deep-seated lump (vulvar Bartholin), abnormal discharge, sometimes pain on intercourse
  • โ†’Standard care: Surgical resection with lymph-node staging; adjuvant radiation/​chemo based on stage

Melanoma (rare)

Aggressive pigmented lesion arising from melanocytes in the vulvar or vaginal mucosa. Vulvar/​vaginal melanoma carries a worse prognosis than cutaneous melanoma due to mucosal location and frequent delayed diagnosis.

  • โ†’Hallmarks: Pigmented lesion (brown, black, blue), often irregular borders, may bleed or itch
  • โ†’Standard care: Wide local excision + sentinel-node biopsy; immunotherapy (checkpoint inhibitors) for advanced disease
  • โ†’Holistic role: General nutrition support, including plenty of fiber; ask your oncology team before taking probiotics during immunotherapy, since a melanoma study found the best outcomes in patients eating enough fiber and not taking probiotics8

Sarcoma (rare)

Rare cancers of mesenchymal origin (muscle, connective tissue). Includes leiomyosarcoma and rhabdomyosarcoma. Rhabdomyosarcoma (especially sarcoma botryoides) is the most common malignant vaginal tumor in children.

  • โ†’Hallmarks: Vaginal mass that may protrude, grape-like clusters in pediatric botryoides type, rapid growth
  • โ†’Standard care: Multimodal sarcoma protocols (surgery + chemo + radiation), often via specialized centers

Vaginal / Vulvar Cancer by the Numbers

7,130
new US cases of vulvar cancer expected in 2026, with about 1,750 deaths13
1 to 2%
of cancers of the female genital tract are vaginal cancers, which makes vaginal cancer rare10
~75%
of vaginal cancers are caused by HPV, which vaccination and cervical screening help prevent19
86%
five-year relative survival while vulvar cancer is localized, as 58% are at diagnosis; about 51% after spread to nearby lymph nodes and 21% after distant spread (US, 2016 to 2022)13
0 of 357
women who kept to lichen sclerosus treatment developed vulvar cancer or precancer over about 5 years of follow-up, against 7 of 150 (4.7%) who did not11
28%
more lung cancers in smokers and asbestos-exposed workers given beta-carotene with vitamin A than placebo; the trial was stopped early6

Symptoms of Vaginal / Vulvar Cancer

Many women dismiss these symptoms as "just yeast" or "just dryness" for months or years before evaluation, which is a common cause of delayed diagnosis.

SymptomWhat happens
Vulvar & Visible Symptoms
Persistent Vulvar Itching (Pruritus)Chronic vulvar itching, especially when it does not respond to typical yeast or eczema treatments, is one of the most common presenting symptoms of vulvar cancer and its precursor lichen sclerosus. Any itching lasting more than 4 weeks despite treatment warrants gynecologic and dermatologic examination.
Visible Lump, Bump or Thickened PatchA new growth on the vulva, often described as a "skin tag," wart, ulcer or thickened patch that does not go away. Any lesion present for more than 4 weeks warrants biopsy, regardless of how innocuous it appears.
White or Red Skin ChangesWhite, parchment-like or wrinkled vulvar skin (suggestive of lichen sclerosus) or red, raw, eczema-like patches (suggestive of vulvar intraepithelial neoplasia, VIN). Both are premalignant and require ongoing dermatologic care to reduce cancer risk.
Vulvar Bleeding or UlcerA non-healing sore or open ulcer on the vulva that bleeds with minor contact or persistently weeps fluid is a strong red flag. Often initially attributed to chafing, infections or eczema, but persistence beyond 3 to 4 weeks must trigger biopsy.
New Pigmented LesionA new dark, brown or black spot on the vulva or vaginal mucosa is concerning for melanoma. Look for ABCDE features: Asymmetry, irregular Borders, variable Color, Diameter greater than 6 mm, Evolution.
Vaginal & Functional Symptoms
Abnormal Vaginal BleedingBleeding between periods, after intercourse, after menopause or any unexplained bleeding pattern can indicate vaginal cancer (or another gynecologic malignancy).
Abnormal Vaginal DischargePersistent watery, bloody or foul-smelling discharge that does not resolve with treatment for typical infections.
Pain with Intercourse (Dyspareunia)New, deep or localized pain with intercourse, often with bleeding or burning afterward. Persistent dyspareunia warrants examination, not avoidance.
Painful or Difficult UrinationBurning with urination from urine contacting a vulvar lesion, or urinary frequency/​urgency from a vaginal mass pressing on the bladder.
Inguinal Lymph Node EnlargementA painless or tender lump in the groin can indicate spread of vulvar or vaginal cancer to the inguinal lymph nodes. Any persistent inguinal node greater than 1 cm that is firm and fixed warrants imaging and biopsy.
โš ๏ธ The 4-⁠Week Rule: Any new vulvar lesion, persistent itching or visible skin change in the lower genital tract that does not resolve within 4 weeks of basic treatment warrants a gynecologic exam with biopsy. Bleeding after menopause, or bleeding you cannot explain, needs a doctor promptly; do not wait 4 weeks.

Causes of Vaginal / Vulvar Cancer

These cancers arise by two main routes: long-lasting infection with certain types of HPV, or long-term skin conditions of the vulva such as lichen sclerosus1.

CauseHow It Contributes to Vaginal / Vulvar CancerWhat Helps
HPV infectionMany vulvar cancers and more than half of vaginal cancers are caused by certain types of HPV, passed on by skin-to-skin genital contact12HPV vaccination, which helps protect against most cancers caused by HPV; cervical screening; condoms, which lower but do not remove the risk12
Lichen sclerosus, lichen planus and VINThese skin conditions of the vulva, and precancerous changes called VIN, can lead to vulvar cancer12Treatment for the skin condition, kept up long term with regular follow-up: in a cohort of 507 women, none who kept to treatment developed cancer or VIN11
SmokingSmoking makes vulvar cancer more likely: it weakens the immune system and the chemicals in cigarettes can cause cancer12Stopping smoking. If you smoke or used to, do not take beta-carotene supplements, which raised lung cancer rates in smokers in two large trials6
A weakened immune systemHIV, lupus or treatments that affect the immune system raise the risk12Effective treatment of the underlying condition, and regular checks of the vulva and vagina
Previous cervical or uterine cancer, or precancerPrecancerous cells in the cervix (CIN) or vagina (VaIN), cervical cancer and uterine cancer treated with radiation all raise the risk, and vaginal cancer can occur after a hysterectomy12Continued checks of the whole lower genital tract rather than ending follow-up after cervical treatment3
Older ageVulvar cancer mostly affects women over 65, and vaginal cancer is most common from 75 12Knowing what is normal for you and getting any lasting change checked, as When to Seek Care sets out
DES exposure before birthA mother who took the hormone medicine DES while pregnant raises the daughter's risk; the rare clear cell adenocarcinoma is linked to it12Telling your doctor if you know you were exposed, so checks can be planned

How Vaginal / Vulvar Cancer Is Diagnosed

Diagnosis is built from inspection (the eye is the most powerful first tool here) plus biopsy plus imaging for staging. Because the vulva is visible on self-exam and the vagina is seen on a pelvic exam, vigilant self-exam, regular pelvic exams and prompt evaluation of any persistent change are the main levers in early diagnosis.

TestWhat it shows
At-Home Screening & Surveillance
These tools do not replace a medical exam, but they can catch early lesions and prompt women to seek timely evaluation:
Monthly Vulvar Self-Exam (with mirror)Once a month, in good light with a hand mirror, examine the labia majora, labia minora, clitoral area, vaginal opening and perineum. Look for new lumps, white/red/pigmented patches, ulcers or asymmetry. It is a simple and useful early-detection habit.
Symptom Diary (4-⁠Week Rule)Track any vulvar or vaginal symptom (itching, burning, discharge, bleeding, new lesion) by date and treatment tried. Any symptom that has not resolved within 4 weeks despite reasonable treatment is the signal to escalate to a gynecologic exam.
Clinical & Lab Workup
Clinical Inspection & VulvoscopyThe most important diagnostic tool. A focused vulvar exam, sometimes with magnification (vulvoscopy) and application of acetic acid or toluidine blue to highlight suspicious areas. Annual exam by a gynecologist familiar with vulvar disease is standard for women with lichen sclerosus or prior VIN.
Punch Biopsy (Definitive Test)Any suspicious vulvar or vaginal lesion is biopsied in the office under local anesthesia using a small (3 to 4 mm) skin punch or cervical biopsy forceps. This is the only way to confirm or exclude cancer or precancer. Multiple biopsies should be taken for multifocal disease.
HPV & p16 TestingOn the biopsy specimen, p16 IHC and HPV testing identify HPV-related disease, which carries a different prognosis and may inform immunotherapy decisions in advanced disease.
Pelvic MRI & CT/PET ImagingPelvic MRI defines the size, depth and relationship of the tumor to urethra, anus and pelvic structures, critical for surgical planning. CT chest/​abdomen/​pelvis evaluates lymph nodes and distant disease. PET-CT is used for high-risk disease and restaging.
Colposcopy & Cystoscopy/​ProctoscopyFor vaginal cancer, colposcopy of the entire vaginal mucosa identifies multifocal disease (common). Cystoscopy and proctoscopy are added for larger tumors near the urethra/​bladder or anus/rectum to assess invasion.

Conventional and Holistic Treatment for Vaginal / Vulvar Cancer

For vaginal and vulvar cancer, standard oncology is the primary and curative treatment. The holistic approach described here is complementary, designed to be used alongside surgery, radiation, chemotherapy and immunotherapy under oncology supervision, not in place of them.

๐ŸŒฟ HOLISTIC
๐Ÿ’Š CONVENTIONAL
๐ŸŒฟ

Holistic / Functional Approach

Nutrition through treatment, stopping smoking, lichen sclerosus skin care, and help with side effects and recovery

Primary Role
Supportive nutrition, lichen sclerosus skin care, surgical recovery, radiation-side-effect mitigation
Duration
Continuous, from diagnosis through active treatment and into survivorship
Effect on Disease
May help tolerance and recovery; no diet or supplement has been shown to lower recurrence. Keeping up lichen sclerosus treatment was linked with fewer vulvar cancers11
Goal
Strong recovery, fewer side effects and healthy vulvar skin

Full Holistic Approach Includes

  • Pre-treatment nutritional optimization, protein about 0.5 to 0.7 g per pound (1.2 to 1.5 g/kg), correct vitamin D and ferritin, anti-inflammatory diet
  • Stopping smoking, which lowers the chance of vulvar cancer; smoking weakens the immune system12
  • General health: vitamin D at a dose your clinician sets, zinc and vitamin A from food, and sleep
  • Lichen sclerosus skin care, dermatologist-prescribed topical steroids/​calcineurin inhibitors, gentle barrier creams, avoid irritants
  • Surgical recovery, protein-anchored meals, scar massage, pelvic floor physical therapy, vaginal moisturizers post-radiation
  • Radiation side-effect support, vaginal dilator program, vaginal moisturizers, careful skin care of the radiation field
  • Sleep, stress and mind-body work (breathwork, meditation, counseling) for diagnosis-related sexual and intimacy distress
  • Survivorship, ongoing dermatologic care for lichen sclerosus, HPV vaccination3 if not previously given (in selected cases), risk reduction work
โš ๏ธ Note on supplements during treatment: Several supplements (high-dose antioxidants, St. John's wort, grapefruit, some herbal extracts) interfere with chemotherapy and radiation. Always disclose every supplement to your oncology team and pharmacist.

Evidence-Based Supplements for Vaginal / Vulvar Cancer

Supportive supplements during and after cancer treatment must be coordinated with the oncology team, especially given the immune-related and HPV-driven nature of these cancers. The list below sets out common supportive options and what the evidence shows for each; always confirm with your oncologist before adding any.

Supplement What it is for Typical range Timing Notes & cautions
Vitamin D3 (with K2)In a randomized trial of 25,871 adults, vitamin D did not lower cancer rates16. Also supports bone health after surgical menopause.D3: set the dose with your clinician; most adults need no blood test first; K2 (MK-⁠7): 100 to 200 mcg per dayWith a fat-containing meal, morningDiscuss with oncologist before/​during treatment. If you take warfarin, clear any vitamin K supplement with the clinician managing your anticoagulation before starting or stopping it: vitamin K antagonizes warfarin, and changing your intake destabilizes the INR. Consistency matters more than avoidance. This does not apply in the same way to direct oral anticoagulants such as apixaban or rivaroxaban, but tell your prescriber about any supplement you take.
ZincEssential for immune function, T-cell activity, skin and mucosal repair, and wound healing post-surgery. Frequently low in vegetarians and the elderly.15 to 30 mg per dayWith meals (food prevents nausea)If using long-term at higher doses, add 1 to 2 mg copper to prevent imbalance.
Vitamin A (Mixed Carotenoids or Modest Retinol)Needed for skin and mucosal health and immune function; it has not been shown to clear HPV or prevent these cancers.From food first. If supplementing, 10,000 IU mixed carotenoid blend. Blends containing beta-carotene are not for current or former smokers (CARET and ATBC trials)6With a fat-containing mealDo not take beta-carotene supplements if you smoke or used to smoke: the CARET and ATBC trials both found supplemental beta-carotene increased lung cancer incidence and mortality in smokers, and CARET was stopped early for harm. Beta-carotene from food is not the same thing and is safe. Avoid high-dose retinol in pregnancy and in liver disease.6 Food sources (sweet potato, eggs and liver except in pregnancy) always first choice.
Vitamin CSupports collagen synthesis after surgery and immune function. Oral intake supportive; high-dose IV is a separate, oncology-supervised intervention.500 to 1,000 mg per day (oral)Divided doses with mealsAvoid high-dose oral antioxidants during specific chemo cycles without oncology guidance.
Omega-⁠3 EPA/DHANot shown to improve treatment tolerance or recovery in these cancers; the evidence is limited.2 to 4 g combined EPA+DHA per dayWith mealsChoose a product with independent third-party purity testing. Hold before surgery per surgical team protocol. At this dose, check with your doctor first if you are pregnant or could become pregnant. In heart trials, fish oil supplements raised the risk of atrial fibrillation, an irregular heartbeat, more so above 1 g a day22, so check this dose with your clinician first. At higher doses fish oil can increase bleeding risk; tell your clinician if you take a blood thinner or have heavy bleeding.
Folate & B12Folate and B12 are needed to make new cells; take them to correct a low level or a diet short of them.400 to 800 mcg folate (folic acid or methylfolate) + 500 to 1,000 mcg B12 per dayMorning with foodDiscuss high-dose folate with oncologist during active chemotherapy; usually fine in survivorship.
Probiotic (Multi-Strain, with Lactobacillus crispatus / rhamnosus)May support the gut after antibiotics; a Cochrane review found only low-certainty evidence that probiotics reduce diarrhea from radiation therapy or chemotherapy18.25 to 50 billion CFU per day, multi-strainEmpty stomach or with light mealAvoid during severe neutropenia without oncology approval. Vaginal probiotic suppositories under gynecologic guidance. Ask your oncology team before taking probiotics during immunotherapy.8
MelatoninStrong circadian regulator, mainly useful for sleep. Not shown to help survival in cancer: small older trials in advanced cancer reported a benefit, but they were low quality and the claim is not established.3 to 20 mg at bedtime (start at 3 mg or less; higher doses only if your oncology team advises them)30 to 60 min before sleepIf you are pregnant or could become pregnant, check with your doctor first. Discuss higher doses with integrative oncology. Melatonin is commonly sold at doses well above what is needed, and more is not better. Start at the lowest available dose. Discuss it with your prescriber if you take sedatives, anticoagulants or immunosuppressants.
Magnesium GlycinateSupports muscle relaxation and sleep.300 to 400 mg elemental magnesium per day.Evening, 30 to 60 min before bedAdjust if loose stools occur. The top of this range is above the 350 mg/day upper intake level for supplemental magnesium; above that, diarrhea is common. With kidney disease, take it only on your clinician's advice.
Iron (only if documented deficiency)Anemia is common from bleeding lesions and chemotherapy. Supplement only when iron studies confirm true deficiency.25 to 65 mg elemental iron per day if deficientEmpty stomach with vitamin C; or oral every other dayConfirm with ferritin and iron studies. Discuss with oncologist. The top of this range sits above the 45 mg/day tolerable upper intake level for adults. That is appropriate only when correcting a confirmed deficiency under clinical supervision, not as general supplementation. Test ferritin first, and retest rather than staying on it indefinitely.
Topical Calendula / Aloe (Radiation Dermatitis Support)Topical, not oral. A meta-analysis of randomized trials found insufficient evidence that calendula or aloe vera treats radiation dermatitis9.Not recommended for radiation dermatitis (a review of trials found insufficient evidence)Not applicableAsk your radiation team before putting anything on treated skin: some preparations include compounds that interfere with radiation delivery.
Ginger Capsules / TeaTrials disagree on whether it adds to standard anti-nausea medicines in chemotherapy, so take it only alongside them. Supplements may be safe in pregnancy17.500 to 1,500 mg per day in divided dosesBefore and during chemo days; with mealsStop 1 week before surgery (mild antiplatelet effect).

What to Expect Over Time

What happens depends on where the cancer is, its size and whether it has spread.

Treatment and supportive care, together
First Weeks

A biopsy under local anesthetic confirms the diagnosis, and a specialist team plans treatment20. Stop smoking if you smoke, and tell the team about every supplement.

Months 1 to 3

Surgery is usually the main treatment for vulvar cancer, sometimes with removal of groin lymph nodes, and radiation therapy or chemotherapy may be added; the main treatment for vaginal cancer is radiation therapy20.

Months 3 to 12

After pelvic radiation therapy, vaginal narrowing and dryness are common, and dilators, moisturizers and pelvic floor physical therapy help; lymphedema can follow groin node surgery5.

Long Term

If you have lichen sclerosus, keep up its treatment and follow-up for life11. Five-year survival for vulvar cancer is about 86% while localized and 21% after distant spread13.

When to Seek Care

See a doctor for a lump, sore, ulcer or wart-like growth, an itch that does not get better, bleeding or bloodstained discharge not related to periods, bleeding after menopause, red, white or dark patches of skin, or a mole that changes12. Anything that lasts a few weeks needs examining and, if it persists, a biopsy, rather than another round of creams4. On chemotherapy, a temperature of 100.5ยฐF (38ยฐC) or higher needs urgent medical attention21.

📬

Get new guides in your inbox. Once a month: new condition guides and research updates, including the trials that did not work. Free, no spam, and you can unsubscribe in one click.

Sign up

Nutrition Alongside Specialist Care

A specialist team plans treatment, usually surgery or radiation therapy. Nutrition works alongside it, never in place of it; stop smoking if you smoke, and tell your oncology team about every supplement. Any lump, ulcer or bleeding that lasts more than a few weeks deserves examination.

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed October 20, 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.7 Nothing on this page treats vaginal or vulvar cancer. Surgery, radiation therapy, chemoradiation and immunotherapy do. Two things are worth acting on. First, these cancers are frequently diagnosed late because the symptoms are attributed to yeast infections, irritation or menopause: any lump, ulcer, persistent itch, color change or bleeding that lasts more than a few weeks deserves examination and, if it persists, a biopsy. Lichen sclerosus in particular is a precancerous condition that needs treatment and monitoring, not just symptom relief. Second, a specific supplement caution appears on this page and it matters: if you smoke or used to smoke, do not take beta-carotene supplements, because two large randomized trials found they increased lung cancer incidence and mortality in smokers. Diet and supplements are not an alternative to surgery, chemotherapy, radiation therapy or immunotherapy, and no dietary change should delay or replace treatment decided with your oncology team. Several supplements interact with cancer treatment, so tell your oncology team about every supplement you take.

  1. On the two pathways: vulvar and vaginal squamous cancers arise either from persistent high-risk HPV infection, typically in younger women and often preceded by high-grade intraepithelial neoplasia, or from chronic inflammatory skin disease, principally lichen sclerosus, typically in older women. The two behave differently, and HPV-associated disease generally has a better prognosis. ↩
  2. On lichen sclerosus. It is a chronic inflammatory condition with a recognized risk of progression to vulvar squamous cell carcinoma, commonly cited at a few percent. Long-term topical corticosteroid treatment relieves symptoms and there is evidence that maintained treatment reduces progression risk, which makes ongoing follow-up and adherence genuinely important rather than merely comfort-driven. ↩
  3. On HPV vaccination and surveillance: HPV vaccination prevents infection with the types causing most HPV-associated vulvar and vaginal cancers. Women with a history of cervical cancer or high-grade cervical intraepithelial neoplasia have a substantially raised risk of vaginal and vulvar disease and warrant continued lower genital tract surveillance rather than being discharged after cervical treatment. ↩
  4. On delay: these cancers are frequently symptomatic for a long period before diagnosis, with delay attributable both to patients not seeking help and to repeated empirical treatment for presumed infection or dermatitis without examination or biopsy. A persistent vulvar lesion that has not responded to treatment should be biopsied rather than treated again. ↩
  5. On treatment effects that nutrition can help with: pelvic radiation therapy causes vaginal stenosis, mucosal atrophy and bowel and bladder effects; lymphedema follows groin node dissection. Maintaining protein and energy intake, managing radiation enteritis, and pelvic floor physical therapy and dilator use all have real supportive roles. ↩
  6. On beta-carotene, the most important supplement caution on this page. The Beta-Carotene and Retinol Efficacy Trial (CARET), N Engl J Med. 1996, PubMed 8602180, and the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study (ATBC), N Engl J Med. 1994, both found that beta-carotene supplementation increased lung cancer incidence and mortality in smokers and asbestos-exposed workers, and CARET was stopped early for harm. Smoking is a risk factor for vulvar cancer, so this readership overlaps directly with the population harmed. Beta-carotene from food is not the same thing and is safe. If supplementing at all, keep the dose modest and prefer food sources. ↩
  7. National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu/mic. ↩
  8. On probiotics during immunotherapy: in 128 melanoma patients on checkpoint inhibitors, higher fiber intake was associated with longer progression-free survival, with the greatest benefit in those eating enough fiber and not using probiotics, PubMed 34941392. ↩
  9. On herbal creams for radiation dermatitis: a meta-analysis of randomized trials in breast cancer radiation therapy found insufficient evidence for calendula or aloe vera, PubMed 37816677. ↩
  10. On vaginal cancer frequency: vaginal cancer accounts for 1 to 2% of cancers of the female genital tract, American Cancer Society. ↩
  11. On lichen sclerosus treatment: in a prospective study of 507 women with biopsy-proven vulvar lichen sclerosus followed for about 5 years, none of the 357 who kept to long-term topical corticosteroid treatment developed vulvar cancer or VIN, against 7 of 150 (4.7%) who did not; symptoms and scarring were also better controlled. It was a single-center cohort, not a randomized trial, PubMed 26070005. ↩
  12. On causes and symptoms: NHS guidance states that many vulvar cancers and more than half of vaginal cancers are caused by HPV; that lichen sclerosus, lichen planus and VIN can lead to vulvar cancer; that smoking, a weakened immune system (such as HIV, lupus or immune-suppressing treatment), cervical precancer or cancer, uterine cancer treated with radiation therapy, older age and exposure to DES before birth raise the risk; and that treating vulvar skin conditions, condoms, stopping smoking, cervical screening and HPV vaccination lower it. It advises seeing a doctor for any of these: a lump, sore or ulcer; bleeding or blood-stained discharge not related to periods; an itch that does not get better; red, white or dark patches; a mole that changes; or bleeding after menopause, NHS, causes of vulvar cancer, NHS, causes of vaginal cancer, NHS, symptoms of vulvar cancer. ↩
  13. On vulvar cancer in the US: SEER estimates 7,130 new cases and 1,750 deaths in 2026. Five-year relative survival (2016 to 2022) is 69.7% overall: 85.5% while the cancer is localized, as 58% are at diagnosis, 51.4% after spread to regional lymph nodes and 20.8% after distant spread, SEER, vulvar cancer stat facts. ↩
  14. On processed meat: the International Agency for Research on Cancer classes processed meat as carcinogenic to humans because it causes colorectal cancer; the classification describes the strength of the evidence, not the size of the risk, so it does not mean processed meat is as dangerous as tobacco, WHO, red meat and processed meat. ↩
  15. On liver and vitamin A in pregnancy: NHS guidance advises avoiding liver and liver products in pregnancy, because their high vitamin A content can harm the baby, and advises everyone to keep vitamin A from food and supplements within 1.5 mg a day, NHS, foods to avoid in pregnancy, NHS, vitamin A. ↩
  16. On vitamin D and cancer: in the VITAL trial, 25,871 adults randomly assigned to 2,000 IU of vitamin D a day or placebo for a median of 5.3 years had no lower rate of invasive cancer, PubMed 30415629. ↩
  17. On ginger and chemotherapy nausea: a 2024 meta-analysis of randomized trials found that ginger capsules taken with standard anti-nausea medicines reduced severe nausea and vomiting, but the NIH's complementary health center states that it is uncertain whether ginger helps alongside standard treatment, and that ginger supplements may be safe in pregnancy, PubMed 38625733, NCCIH, ginger. ↩
  18. On probiotics for treatment-related diarrhea: a Cochrane review of 12 randomized trials in 1,554 people with cancer found only limited, low- or very low-certainty evidence that probiotics prevent or treat diarrhea from radiation therapy or chemotherapy; all the studies were underpowered and none reported serious side effects, PubMed 30168576. ↩
  19. On HPV and vaginal cancer: the American Cancer Society states that about 75% of vaginal cancers are caused by HPV, that vaginal cancer is rare, and that it occurs mainly in older women, American Cancer Society, key statistics for vaginal cancer. ↩
  20. On treatment: NHS guidance states that a biopsy under local anesthetic confirms vulvar cancer, that surgery is usually the main treatment for vulvar cancer, sometimes with removal of lymph nodes in the groin, with radiation therapy or chemotherapy before or after it, and that the main treatment for vaginal cancer is radiation therapy, with surgery or chemotherapy in some cases, NHS, treatment for vulvar cancer, NHS, treatment for vaginal cancer. ↩
  21. On fever during treatment: the National Cancer Institute states that infections during cancer treatment can be life-threatening and need urgent medical attention, that treatments such as chemotherapy raise the risk, and lists a fever of 100.5ยฐF (38ยฐC) or higher among the signs, NCI, infection and neutropenia. ↩
  22. Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of long-term marine omega-⁠3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021;144(25):1981-⁠1990. PubMed 34612056. Seven trials with 81,210 people followed for about 5 years: omega-⁠3 supplements were linked to a higher risk of atrial fibrillation (hazard ratio 1.25), more so in trials of more than 1 g a day (1.49), and the risk rose with each additional gram. ↩